Peringkat dalam Saham
#27074
Mural Oncology Plc, a clinical-stage company, is dedicated to discovering and... Mural Oncology Plc, a clinical-stage company, is dedicated to discovering and advancing immune-based therapies for individuals battling cancer. Its primary drug candidate, nemvaleukin alfa, is currently under investigation as a standalone agent for mucosal melanoma and in partnership with pembrolizumab for platinum-resistant ovarian cancer. Additionally, the company is progressing projects centered on modified interleukin-18 and tumor-specific interleukin-12. Incorporated in 2017, Mural Oncology maintains its headquarters in Dublin, Ireland. By November 15, 2023, the company had transitioned from being a subsidiary of Alkermes plc.
Harga Saham
$2.04
Terakhir disinkronkan: 2025-12-09
Kapitalisasi Pasar
$35.38M
Perubahan (1 tahun)
-2.39%
Perdagangan Mural Oncology plc (MURA)
Harga MURA dengan kapitalisasi pasar B
Kapitalisasi pasar dari Mural Oncology plc(MURA)
Kapitalisasi Pasar: $35.38M
Per August 2026, Mural Oncology plc memiliki kapitalisasi pasar sebesar $35.38M. Ini menjadikan Mural Oncology plc sebagai perusahaan 27074th paling bernilai di dunia menurut data kami. Kapitalisasi pasar adalah nilai total saham beredar dari perusahaan publik dan biasanya digunakan untuk mengukur seberapa besar nilai sebuah perusahaan.
Riwayat kapitalisasi pasar Mural Oncology plc dari 2023 hingga 2026
MURA dibandingkan dengan 5 teratas stocks paling populer
| Harga MURA |
|
Aset B |
Pasar B |
Hasil |
|
|
|
|
$5.301T
|
+14,980,430.71%
|
|
|
|
|
$4.634T
|
+13,095,454.05%
|
|
|
|
|
$4.143T
|
+11,708,180.82%
|
|
|
|
|
$3.589T
|
+10,143,655.51%
|
|
|
|
|
$2.857T
|
+8,073,786.56%
|
